148 related articles for article (PubMed ID: 32503690)
1. Bisbenzylisoquinoline alkaloids and P-glycoprotein function: A structure activity relationship study.
Xu W; Chen S; Wang X; Wu H; Yamada H; Hirano T
Bioorg Med Chem; 2020 Jun; 28(12):115553. PubMed ID: 32503690
[TBL] [Abstract][Full Text] [Related]
2. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells.
Sun YF; Wink M
Phytomedicine; 2014; 21(8-9):1110-9. PubMed ID: 24856768
[TBL] [Abstract][Full Text] [Related]
3. Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cells.
Xu W; Wang X; Chen S; Wu H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Eur J Pharmacol; 2020 Aug; 881():173232. PubMed ID: 32525004
[TBL] [Abstract][Full Text] [Related]
4. Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.
Liao D; Zhang W; Gupta P; Lei ZN; Wang JQ; Cai CY; Vera AA; Zhang L; Chen ZS; Yang DH
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801248
[TBL] [Abstract][Full Text] [Related]
5. Partial synthesis and biological evaluation of bisbenzylisoquinoline alkaloids derivatives: potential modulators of multidrug resistance in cancer.
He P; Sun H; Jian XX; Chen QH; Chen DL; Liu GT; Wang FP
J Asian Nat Prod Res; 2012; 14(6):564-76. PubMed ID: 22587798
[TBL] [Abstract][Full Text] [Related]
6. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells.
Wang FP; Wang L; Yang JS; Nomura M; Miyamoto K
Biol Pharm Bull; 2005 Oct; 28(10):1979-82. PubMed ID: 16204959
[TBL] [Abstract][Full Text] [Related]
7. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of respiratory burst activity in alveolar macrophages by bisbenzylisoquinoline alkaloids: characterization of drug-cell interaction.
Ma JY; Barger MW; Ma JK; Castranova V
Exp Lung Res; 1992; 18(6):829-43. PubMed ID: 1361431
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases.
Xu W; Chen S; Wang X; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Pharmacol Ther; 2021 Jan; 217():107659. PubMed ID: 32800789
[TBL] [Abstract][Full Text] [Related]
10. Histamine release inhibition activity of bisbenzylisoquinoline alkaloids.
Nakamura K; Tsuchiya S; Sugimoto Y; Sugimura Y; Yamada Y
Planta Med; 1992 Dec; 58(6):505-8. PubMed ID: 1484888
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
Zhu X; Sui M; Fan W
Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930
[TBL] [Abstract][Full Text] [Related]
12. Thirteen bisbenzylisoquinoline alkaloids in five Chinese medicinal plants: Botany, traditional uses, phytochemistry, pharmacokinetic and toxicity studies.
Zhang H; Wang X; Guo Y; Liu X; Zhao X; Teka T; Lv C; Han L; Huang Y; Pan G
J Ethnopharmacol; 2021 Mar; 268():113566. PubMed ID: 33166629
[TBL] [Abstract][Full Text] [Related]
13. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
He QY; Meng FH; Zhang HQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674
[TBL] [Abstract][Full Text] [Related]
14. Bisbenzylisoquinoline alkaloids from Cocculus pendulus.
Atta-ur-Rahman ; Atia-tul-Wahab ; Zia Sultani S; Nawaz SA; Choudhary MI
Nat Prod Res; 2009; 23(14):1265-73. PubMed ID: 19479625
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of bisbenzylisoquinoline alkaloids on nitric oxide production in activated macrophages.
Kondo Y; Takano F; Hojo H
Biochem Pharmacol; 1993 Dec; 46(11):1887-92. PubMed ID: 7505581
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic bisbenzylisoquinoline alkaloids from Stephania epigaea.
Lv JJ; Xu M; Wang D; Zhu HT; Yang CR; Wang YF; Li Y; Zhang YJ
J Nat Prod; 2013 May; 76(5):926-32. PubMed ID: 23621840
[TBL] [Abstract][Full Text] [Related]
17. Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.
Hsiao SH; Lu YJ; Yang CC; Tuo WC; Li YQ; Huang YH; Hsieh CH; Hung TH; Wu CP
J Nat Prod; 2016 Aug; 79(8):2135-42. PubMed ID: 27504669
[TBL] [Abstract][Full Text] [Related]
18. The interaction between human breast cancer resistance protein (BCRP) and five bisbenzylisoquinoline alkaloids.
Tian Y; Qian S; Jiang Y; Shen Q; Zheng J; Zhou H; Zeng S
Int J Pharm; 2013 Sep; 453(2):371-9. PubMed ID: 23742976
[TBL] [Abstract][Full Text] [Related]
19. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots.
Chan EWC; Wong SK; Chan HT
J Integr Med; 2021 Jul; 19(4):311-316. PubMed ID: 33583757
[TBL] [Abstract][Full Text] [Related]
20. Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase.
Zhang W; Yang S; Liu J; Bao L; Lu H; Li H; Pan W; Jiao Y; He Z; Liu J
BMC Cancer; 2019 Oct; 19(1):1009. PubMed ID: 31660888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
